Oleandomycin

Oleandomycin

Gene therapy
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	J01FA05 (WHO)
Physiological data
Legal status
Pharmacokinetic data
Identifiers
IUPAC name (3R,5R,6S,7R,8R,11R,12S,13R,14S,15S)-14-((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-6-hydroxy-12-((2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yloxy)-5,7,8,11,13,15-hexamethyl-1,9-dioxaspiro[2.13]hexadecane-4,10-dione
CAS Number	3922-90-5 Y
PubChem Template:Abbreviation	5284598
ChemSpider	4447646 Y
UNII	P8ZQ646136
ChEMBL	ChEMBL606258 N
Chemical and physical data
Formula	C35H61NO12
Molar mass	687.858 g/mol
3D model (JSmol)	Interactive image
SMILES O=C4[C@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)[C@@H]([C@@H](O[C@@H]1O[C@H]([C@H](O)[C@@H](OC)C1)C)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@H](C)C[C@@]43OC3)C)C
InChI InChI=1S/C35H61NO12/c1-16-14-35(15-43-35)32(40)19(4)27(37)18(3)22(7)46-33(41)21(6)31(47-26-13-25(42-11)28(38)23(8)45-26)20(5)30(16)48-34-29(39)24(36(9)10)12-17(2)44-34/h16-31,34,37-39H,12-15H2,1-11H3/t16-,17+,18-,19+,20+,21+,22+,23-,24-,25-,26-,27-,28-,29+,30-,31-,34-,35-/m0/s1 Y Key:RZPAKFUAFGMUPI-KGIGTXTPSA-N Y
Template:XmarkY (what is this?)  (verify)

WikiDoc Resources for Oleandomycin
Articles
Most recent articles on Oleandomycin Most cited articles on Oleandomycin Review articles on Oleandomycin Articles on Oleandomycin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Oleandomycin Images of Oleandomycin Photos of Oleandomycin Podcasts & MP3s on Oleandomycin Videos on Oleandomycin
Evidence Based Medicine
Cochrane Collaboration on Oleandomycin Bandolier on Oleandomycin TRIP on Oleandomycin
Clinical Trials
Ongoing Trials on Oleandomycin at Clinical Trials.gov Trial results on Oleandomycin Clinical Trials on Oleandomycin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Oleandomycin NICE Guidance on Oleandomycin NHS PRODIGY Guidance FDA on Oleandomycin CDC on Oleandomycin
Books
Books on Oleandomycin
News
Oleandomycin in the news Be alerted to news on Oleandomycin News trends on Oleandomycin
Commentary
Blogs on Oleandomycin
Definitions
Definitions of Oleandomycin
Patient Resources / Community
Patient resources on Oleandomycin Discussion groups on Oleandomycin Patient Handouts on Oleandomycin Directions to Hospitals Treating Oleandomycin Risk calculators and risk factors for Oleandomycin
Healthcare Provider Resources
Symptoms of Oleandomycin Causes & Risk Factors for Oleandomycin Diagnostic studies for Oleandomycin Treatment of Oleandomycin
Continuing Medical Education (CME)
CME Programs on Oleandomycin
International
Oleandomycin en Espanol Oleandomycin en Francais
Business
Oleandomycin in the Marketplace Patents on Oleandomycin
Experimental / Informatics
List of terms related to Oleandomycin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Oleandomycin is a macrolide antibiotic. It is synthesized from strains of Streptomyces antibioticus. It is weaker than erythromycin.

It used to be sold under the brand name Sigmamycine, combined with tetracycline, and made by the company Rosa-Phytopharma in France.